|
Sign In to gain access to subscriptions and/or personal tools.
|
Atherosclerosis and autoimmunity
P A Gordon
The Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London SE1 7EH, UK 106404.2325{at}compuserve.com
J George
Department of Medicine B, Research Unit of Autoimmune Diseases, Chaim Sheba Medical Centre, Tel-Hashomer, Israel
M A Khamashta
The Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London, UK
D Harats
Department of Medicine B, Research Unit of Autoimmune Diseases, Chaim Sheba Medical Centre, Tel-Hashomer, Israel
G Hughes
The Lupus Research Unit, Rayne Institute, St Thomas' Hospital, London, UK
Y Shoenfeld
Department of Medicine B, Research Unit of Autoimmune Diseases, Chaim Sheba Medical Centre, Tel-Hashomer, Israel
Novel risk factors for the progression of atherosclerosis such as C-reactive protein (CRP) and adhesion molecules have stimulated much recent interest in the role of inflammation in athero-sclerotic disease. There is also evidence emerging that autoimmunity may have a role in the pathogenesis of atherosclerosis. In this article we explore the evidence for the role of autoimmunity in human atherosclerosis, both in the general population and in the context of the antiphospholipid syndrome. In particular we will focus on several autoantigens, review the evidence for their role in the process of atherosclerosis and the nature of the immune responses.
Key Words: OxLDL lipoprotein (a) Hughes' Syndrome heat shock protein
Lupus, Vol. 10, No. 4,
249-252 (2001)
DOI: 10.1191/096120301680416922

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Charakida, C. Besler, J. R. Batuca, S. Sangle, S. Marques, M. Sousa, G. Wang, D. Tousoulis, J. Delgado Alves, S. P. Loukogeorgakis, et al.
Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome
JAMA,
September 16, 2009;
302(11):
1210 - 1217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Der, G. Kerekes, K. Veres, P. Szodoray, J. Toth, G. Lakos, G. Szegedi, and P. Soltesz
Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome
Lupus,
July 1, 2007;
16(7):
497 - 503.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M Szyper-Kravitz, M Harel, B Gilburd, E Trubniykov, Y. Schiffenbauer, and Y Shoenfeld
Application of a Static Fluorescence-Based Cytometer: The Cellscan in Clinical Immunology
Lupus,
July 1, 2006;
15(7):
436 - 441.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pullmann Jr, M. Skerenova, J. Lukac, J. Hybenova, V. Melus, P. Kubisz, J. Rovensky, and R. Pullmann
Factor V Leiden and Prothrombin G20210A Mutations and the Risk of Atherothrombotic Events in Systemic Lupus Erythematosus
Clinical and Applied Thrombosis/Hemostasis,
July 1, 2004;
10(3):
233 - 238.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schattner and M. H. Liang
The Cardiovascular Burden of Lupus: A Complex Challenge
Arch Intern Med,
July 14, 2003;
163(13):
1507 - 1510.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Xia, W. H. Ling, J. Ma, D. D. Kitts, and J. Zawistowski
Supplementation of Diets with the Black Rice Pigment Fraction Attenuates Atherosclerotic Plaque Formation in Apolipoprotein E Deficient Mice
J. Nutr.,
March 1, 2003;
133(3):
744 - 751.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|